Blueprint Medicines
BPMC · NASDAQ
Price unavailable right now.
No price history for this range.
Who owns BPMC
Largest institutional holders, from their latest 13F filings
The 6 largest institutions hold 0.2% of BPMC’s shares.
- Haviland (Kathryn D)0.1%
- Lydon (Nicholas B.)0.1%
- Nomura Asset Management (UK) Ltd.0.0%
- Lindbrook Capital, LLC0.0%
- Next 2 largest institutions0.0%
- All other shareholders99.8%
| Holder | Shares | % of shares |
|---|---|---|
| Haviland (Kathryn D) | 73.23K | 0.11% |
| Lydon (Nicholas B.) | 55.78K | 0.09% |
| Nomura Asset Management (UK) Ltd. | 12.46K | 0.02% |
| Lindbrook Capital, LLC | 309 | 0.00% |
| Avantis Investors_NLE | 16 | 0.00% |
| Cassady Schiller Wealth Management, LLC | 8 | 0.00% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| NexPoint Merger Arbitrage Fund | 428.41K | 0.66% |
| BB Biotech Fd | 284.90K | 0.44% |
| BSF Global Event Driven Fund | 55.94K | 0.09% |
| Canada Pension Plan Investment Board | 46.00K | 0.07% |
| WTC-CIF II SMID Research Fund | 40.93K | 0.06% |
Short interest
Settled Jul 15, 2025
- Shares short
- 1.67M
- Days to cover
- 1.00
- % of shares outstanding
- 2.58%
- Average daily volume
- 3.51M
- Change since last report
- −54.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.